Sabrina Annick Assoumou, MD, MPH

Assistant Professor, Medicine

Sabrina Assoumou

Biography

Dr. Assoumou is an Assistant Professor of Medicine at the Boston University School of Medicine. She trained at the combined Internal Medicine/Pediatrics residency at Brown University and completed infectious diseases fellowship at Beth Israel Deaconess Medical Center in Boston. Her current research focuses on improving outcomes in individuals infected with human immunodeficiency virus (HIV) and/or hepatitis C (HCV) using comparative and cost-effectiveness analyses.

Education

  • University of Rochester School of Medicine & Dentistry, MD
  • Harvard School of Public Health, MPH
  • Williams College, BA

Publications

  • Published on 11/12/2018

    Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2018 Nov 12. PMID: 30467088.

    Read at: PubMed
  • Published on 1/18/2018

    Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 Jan 18; 66(3):376-384. PMID: 29020317.

    Read at: PubMed
  • Published on 1/1/2017

    Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344. PMID: 29176099.

    Read at: PubMed
  • Published on 12/27/2016

    Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266. PMID: 28480259.

    Read at: PubMed
  • Published on 11/17/2015

    Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr; 23(4):274-81. PMID: 26572798.

    Read at: PubMed
  • Published on 3/31/2015

    Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5; 162(9):619-29. PMID: 25820703.

    Read at: PubMed
  • Published on 5/19/2014

    Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014; 9(5):e97317. PMID: 24842841.

    Read at: PubMed
  • Published on 5/14/2014

    Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009. PMID: 25734083.

    Read at: PubMed
  • Published on 5/1/2014

    Assoumou SA, Huang W, Horsburgh CR, Mus, Linas BP. Quality of hepatitis C care at an urban tertiary care medical center. J Health Care Poor Underserved. 2014 May; 25(2):705-16. PMID: 24858880.

    Read at: PubMed
  • Published on 1/28/2014

    Linas BP, Barter DM, Leff JA, DiLorenzo M, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Freedberg KA. The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients. AIDS. 2014 Jan 28; 28(3):365-76. PMID: 24670522.

    Read at: PubMed

View 2 more publications: View full profile at BUMC

View all profiles